In 2023, the average length of stay for patients with malignant neoplasm of the uterus in the UK was slightly higher than the forecasted 2024 value of 3.4 days. The forecasted data highlights a continual decrease from 2024 to 2028, predicting a decline from 3.4 days to 2.8 days. The year-on-year percentage variations reflect gradual reductions: 2.94% from 2024 to 2025, 6.06% from 2026 to 2027, and 3.45% from 2027 to 2028. The compound annual growth rate (CAGR) from 2024 to 2028 shows an average annual decrease of approximately 4.5%.
Future trends to watch include the impact of advancements in medical technology and treatment methods, which could further reduce hospital stays. Additionally, improvements in outpatient care and early detection could influence these figures, as they may lead to fewer complications and shorter recovery times within hospitals.
